---
layout: post
title: "Adjustments to Aggregate Production Quotas for Certain Schedule II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine and Pseudoephedrine for 2020, in Response to the Coronavirus Disease 2019 Public Health Emergency"
date: 2026-02-05 19:09:22 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-07593
original_published: 2020-04-10 00:00:00 +0000
significance: 8.00
---

# Adjustments to Aggregate Production Quotas for Certain Schedule II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine and Pseudoephedrine for 2020, in Response to the Coronavirus Disease 2019 Public Health Emergency

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 10, 2020 00:00 UTC
**Document Number:** 2020-07593

## Summary

The Drug Enforcement Administration is adjusting the 2020 aggregate production quotas for certain controlled substances in schedule II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine and pseudoephedrine. This increase is in response to the current nationwide COVID-19 public health emergency as declared by the Secretary of Health and Human Services on January 31, 2020.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/04/10/2020-07593/adjustments-to-aggregate-production-quotas-for-certain-schedule-ii-controlled-substances-and)
- API: https://www.federalregister.gov/api/v1/documents/2020-07593

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
